Jacobs Levy Equity Management, Inc Mustang Bio, Inc. Transaction History

Jacobs Levy Equity Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.58 - $3.36 $122,010 - $158,897	-47,291 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.7 - $3.81 $2.64 Million - $3.73 Million	-978,568 Reduced 95.39%	47,291 $157,000
Q1 2021 May 17, 2021	SELL	$3.02 - $5.16 $88,434 - $151,100	-29,283 Reduced 2.78%	1,025,859 $3.41 Million
Q4 2020 Feb 16, 2021	BUY	$2.66 - $4.18 $1.25 Million - $1.97 Million	470,457 Added 80.46%	1,055,142 $3.99 Million
Q3 2020 Nov 16, 2020	BUY	$3.01 - $3.88 $1.27 Million - $1.63 Million	421,175 Added 257.58%	584,685 $1.84 Million

Q2 2020 Aug 17, 2020	BUY	$2.33 - $4.6 $380,978 - $752,146	163,510 New	163,510 $520,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $35.8M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.